Colon Cancer

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season. Read More

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be useful in colon cancer therapy. Read More

“Orphan” enzyme may play role in cancer growth, new research suggests. Read More

Vanderbilt-Ingram Cancer Center has initiated tumor mutation testing for a limited number of patients with metastatic colorectal cancer. Read More

Vanderbilt-Ingram Cancer Center researchers have identified a new population of intestinal stem cells that may hold clues to the origin of colorectal cancer. Read More

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease. Read More

Women who eat at least three servings of fish per week have a reduced risk of developing some types of colon polyps according to a new study by Vanderbilt-Ingram Cancer Center investigators. Read More

Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis. Read More

A protein critical in heart development may also play a part in colon cancer progression. Read More

Vanderbilt researchers have identified small molecules that can restore normal protein expression in human colorectal carcinoma cells and prevent invasive cancer growth. Read More

Loss of the protein p120 in the intestinal lining sets the stage for tumor formation. Read More

Increasing an enzyme required for a type of colon tissue may help dampen inflammation, a known risk factor for colon cancer. Read More